| Literature DB >> 19464531 |
R van Houdt1, F D H Koedijk, S M Bruisten, E L M Op de Coul, M L A Heijnen, Q Waldhober, I K Veldhuijzen, J H Richardus, M Schutten, G J J van Doornum, R A de Man, S J Hahné, R A Coutinho, H J Boot.
Abstract
In November 2002, the Netherlands adopted a vaccination program targeted at behavioural risk groups. Between January 2003 and December 2007, 1386 patients acutely infected with HBV were reported. Reported cases declined from 326 in 2003 to 220 in 2007. Sexual intercourse was the most frequently reported mode of transmission (65%), especially among men having sex with men. Genotypes A and D remained predominant. In total, 40,600 participants were fully vaccinated, the overall compliance was 62%, and the estimated overall program coverage was 12% of the at-risk population. With more effort, more susceptibles may be reached, but the program will not be sufficient to substantially reduce HBV in the Netherlands. Therefore, universal vaccination should be considered.Entities:
Mesh：
Substances：
Year: 2009 PMID： 19464531 DOI： 10.1016/j.vaccine.2009.03.072
Source DB: PubMed Journal: Vaccine ISSN： 0264-410X Impact factor: 3.641